Meanwhile, a study by Wiesmayr et al. in pediatric heart or lung transplant recipients showed that EBV-positive PTLD patients displayed increased proportions of early-differentiated CD56dim CD16− cells and CD56− CD16+ NK cells in peripheral blood [34]. Here, FCGR3A is linked to post-transplant lymphoproliferative disease.